Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis

Langenbeck's Archives of Surgery

Volumn 396, Issue 5, 2011, Pages 615-623

  Deng, Jingyu ^a   Liang, Han ^a   Sun, Dan ^a   Pan, Yi ^a   Liu, Yong ^a   Wang, Dianchang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Gastric neoplasm; Multiple analyses; Prognosis; Tumor metastasis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STATISTICS AS TOPIC; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR BURDEN; YOUNG ADULT;

EID: 80052566364     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-011-0753-3     Document Type: Article

References (37)

1. Schwarz RE, Zagala-Nevarez K (2002) Recurrence patterns after radical gastrectomy for gastric cancer: prognosis factors and implications for postoperative adjuvant therapy. Ann Surg Oncol 9:394-400 (Pubitemid 34496728)
2. Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M (2003) Ratio between metastatic and extended lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10:1077-1085 (Pubitemid 40486832)
3. Coburn NG, Swallow CJ, Kiss A, Law C (2006) Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 107:2143-2151 (Pubitemid 44665647)
4. Abe N, Watanabe T, Suzuki K, Machida H, Toda H, Nakaya Y, Masaki T, Mori T, Sugiyama M, Atomi Y (2002) Risk factors predictive of lymph node metastasis in depressed early gastric cancer. Am J Surg 183:168-172 (Pubitemid 34246430)
5. Japanese Gastric Cancer Association (1998) Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1:10-24
6. Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J (2002) How many nodes must be examined to accurately stage gastric adenocarcinomas? Results from a population based study. Cancer 94:2862-2866 (Pubitemid 34547684)
7. Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604-1608 (Pubitemid 15062653)
8. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9:775-784
9. Inoue K, Nakane Y, Iiyama H, Sato M, Kanbara T, Nakai K, Okumura S, Yamamichi K, Hioki K (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27-34 (Pubitemid 34262894)
10. Bunt AMG, Hermans J, Smit VTHBM, van de Velde CJH, Fleuren GJ, Bruijn JA (1995) Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 13:19-25
11. Hundahl SA, Macdonald JS, Benedetti J (2002) Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 9:278-286 (Pubitemid 34298633)
12. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767-2773 (Pubitemid 41079893)
13. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJH (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908-914 (Pubitemid 29141051)
14. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 79:1522-1530 (Pubitemid 29116815)
15. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J (2004) Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 91:283-287 (Pubitemid 38375766)
16. Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A (2004) Italian Gastric Cancer Study Group. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30:303-308 (Pubitemid 38425649)
17. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K (2008) JCOG. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 395:453-462
18. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069-2077 (Pubitemid 41095139)
19. Songun I, Putter H, Kranenbarg EM-K, Sasako M, van de Velde CJH (2010) Surgical treatment of gastric cancer: 15-year followup results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol 11:439-449
20. Noguchi Y, Imada T, Matsumoto A, Coit DG, Brennan MF (1989) Radical surgery for gastric cancer-a review of the Japanese experience. Cancer 64:2053-2062 (Pubitemid 19280403)
21. Sobin LH, Wittekind CH (1997) International Union Against Cancer (UICC): TNM Classification of Malignant Tumors, 5th edn. Wiley, New York
22. Deng JY, Liang H, Wang DC, Sun D, Ding X, Pan Y, Liu Y (2010) Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol 17:1043-1051
23. Hundahl SA, Phillips JL, Menck HR (2000) The National Cancer Data Base Report on poor survival of U. S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 88:921-932 (Pubitemid 30091113)
24. Katai H, Yoshimura K, Maruyama K, Sasako M, Sano T (2000) Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma. Cancer 88:1796-1800 (Pubitemid 30212987)
25. Aiko T, Sasako M (1998) The new Japanese Classification of Gastric Carcinoma: points to be revised. Gastric Cancer 1:25-30
26. Wu CW, Hsieh MJ, Lo SS, Tsay SH, Liu WY, P'eng FK (1994) Lymph node metastasis from carcinoma of the distal one-third of the stomach. Cancer 73:2059-2064
27. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 98:775-784
28. Baxter NN, Tuttle TM (2005) Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 12:981-987 (Pubitemid 41660673)
29. Hundahl SA, Menck HR, Mansour EG, Winchester DP (1997) The National Cancer Data Base report on gastric carcinoma. Cancer 80:2333-2341 (Pubitemid 28007405)
30. Schwarz RE, Smith DD (2007) Clinical impact of lymphadenectomy extent in resectble gastric cancer of advanced stage. Ann Surg Oncol 14:317-328 (Pubitemid 46175271)
31. de Manzoni G, Verlato G, Roviello F, Morgagni P, Di Leo A, Saragoni L, Marrelli D, Kurihara H, Pasini F (2002) The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 87:171-174
32. Hartgrink HH, van de Velde CJH (2005) Status of extended lymph node dissetion: locoregional control is the only way to survival gastric cancer. J Surg Oncol 90:153-165 (Pubitemid 40741180)
33. Smith DD, Schwarz RR, Schwartz RE (2005) Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-Population Database. J Clin Oncol 23:7114-7124
34. Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D, Roviello F, Morgagni P, Saragoni L, Natalini G, De Santis F, Baiocchi L, Coniglio A (2008) Italian Research Group for Gastric Cancer Study (GIRCG). The prognostic value of Nratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol 34:159-165
35. Johnson PM, Porter GA, Ricciardi R, Baxter NN (2006) Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 24:3570-3575 (Pubitemid 46630528)
36. Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH (2009) Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol 35:409-414
37. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Ohro S, Tatebe S, Tsujitani S, Ikeguchi M (2007) Recurrence in early gastric cancer-presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Hepatogastroenterology 54:620-624 (Pubitemid 46724743)